To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06840834
Title Evaluating Ivonescimab As a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy (Bi-MAPS)
Acronym Bi-MAPS
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Besançon - CHU Besançon France Details
Brest - CHU Brest France Details
Caen - CHU Caen France Details
Clermont-Ferrand - Centre Jean Perrin Clermont-Ferrand France Details
Créteil - CHI Créteil France Details
Grenoble - CHU Grenoble France Details
Le Mans - CHG Le Mans France Details
Lille - CHU Lille France Details
Marseille - APHM Marseille France Details
Montpellier - CHU Montpellier France Details
Mulhouse - GHRMSA Mulhouse France Details
Nantes - Hôpital Laennec Nantes France Details
Paris - Bichat Paris France Details
Bordeaux - CHU Pessac France Details
Lyon - HCL Pierre-benite France Details
Strasbourg - Nouvel Hôpital Civil Strasbourg France Details
Toulon - CHI Toulon France Details
Toulouse - CHU Toulouse France Details
Tours - CHU Tours France Details
Metz - Hôpital Robert Schuman Vantoux France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field